Table 2.
Changes in the clinical parameters in the two protocols during the trial phase
Parameter | Moxifloxacin | Control group | ||
---|---|---|---|---|
Baseline | 6 months | Baseline | 6 months | |
Clinical Atthacment Level (mean±SD) | 4.92±0.5* | 3.14±0.6** | 4.93±0.4* | 3.77±0.4** |
Probing Depth (mean±SD) | 4.27±0.4* | 3.08±0.6** | 4.34±0.5* | 3.5±0.4** |
SD: standard deviation;
Changes were detected among the two time evaluations (repeated-measures ANOVA p<0.001);
Changes were perceived between the treatments (t -test p<0.001).